Scientists who work in mycology — the study of fungi — say there is precious little money available to study Candida auris, according to an article on the STAT News website.
Candida auris is making news for its ability to resist multiple antifungal drugs and settle into hospital rooms so persistently it can take renovations to get rid of it.
The head of mycotic diseases at the Centers for Disease Control and Prevention (CDC) acknowledged his field hasn’t attracted the same kind of research dollars as other pathogens.
A high proportion of people who have been diagnosed with C. auris have died — the CDC estimates it’s between 30 percent and 60 percent.
Healthcare Construction Infection Control: Essential CDC Guidelines for Active Facilities
Protecting the Most Vulnerable: Inside the NICU
Kora Behavioral Health Officially Opens in Lancaster, Pennsylvania
Small Details, Real Impact: Design With Caregivers in Mind
Safety Features Senior Living Communities Prioritize